8-K

                                       3

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549
                                  ------------
                                    FORM 8-K
                                  ------------
                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934

                Date of Report (Date of Earliest Event Reported):
                                   May 3, 2005

                           USANA HEALTH SCIENCES, INC.

             (Exact name of registrant as specified in its charter)

                           Commission File No. 0-21116

              Utah                               87-0500306

 (State or other jurisdiction of        (IRS Employer Identification

         incorporation)                            Number)

                           3838 West Parkway Boulevard
                           Salt Lake City, Utah 84120
               (Address of principal executive offices, Zip Code)

       Registrant's telephone number, including area code: (801) 954-7100

   Former name or former address, if changed since last report: Not Applicable








Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:


[  ] Written communications pursuant to Rule 425 under the Securities Act
     (17 CFR 230.425)


[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
     (17 CFR 240.14a-12)


[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))


[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))



Item 8.01         Other Events

On May 3, 2005, USANA Health Sciences, Inc. issued a press release
announcing that its board of directors has authorized an additional $30 million
for share repurchases of its outstanding common stock. The release also
announced that share repurchases will be made from time-to-time, in the open
market, through block trades or otherwise, and will be funded with internally
generated cash. A copy of the press release is furnished herewith as Exhibit
99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The company will also post this document on its corporate website,
www.usanahealthsciences.com, under the "investors" link.


Item 9.01         Financial Statements and Exhibits (furnished herewith)

                  (c)      Exhibits

Exhibit 99.1      Press release issued by USANA Health Sciences, Inc. dated May
                  3, 2005


                                       2


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                      USANA HEALTH SCIENCES, INC.


                                      By: /s/ Gilbert A. Fuller
                                          _____________________________

                                      Gilbert A. Fuller, Chief Financial Officer

Date: May 5, 2005


                                       3

EX-99.1

                                                                    Exhibit 99.1

USANA Board Authorizes Additional $30 Million for Share Repurchases

    SALT LAKE CITY--(BUSINESS WIRE)--May 3, 2005--USANA Health
Sciences Inc. (Nasdaq: USNA) today announced that its board of
directors has authorized an additional $30 million for share
repurchases of its outstanding common stock.
    Repurchases will be made from time to time, in the open market,
through block trades or otherwise, and will be funded with internally
generated cash. The number of shares to be purchased and the timing of
purchases will be based on market conditions, the level of cash
balances, general business opportunities, and other factors.
    On April 22, 2005, USANA announced that it had increased the
amount available for additional share repurchases to $10 million.
Repurchases under that previous authorization have been completed.
During 2004, the company repurchased a total of 1.2 million shares for
a total investment of $34.9 million or an average of $29.02 per share.
    USANA had 18,927,128 common shares outstanding as of April 29,
2005.

    About USANA

    USANA develops and manufactures high-quality nutritional and
personal care products that are sold directly to Associates and
Preferred Customers throughout the United States, Canada, Australia,
New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico,
the Netherlands, and the United Kingdom. More information on USANA can
be found at http://www.usanahealthsciences.com.

    Safe Harbor

    This press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act and Section 21E of the
Securities Exchange Act. Actual results could differ materially from
those projected in these forward-looking statements, which involve a
number of risks and uncertainties, including reliance upon our network
of independent Associates, the governmental regulation of our
products, manufacturing and marketing risks, and uncertainties
associated with our planned international expansion. The contents of
this release should be considered in conjunction with the risk
factors, warnings, and cautionary statements that are contained in our
most recent filings with the Securities and Exchange Commission.

    CONTACT: USANA Health Sciences Inc., Salt Lake City
             Riley Timmer, 801-954-7100
             investor.relations@us.usana.com